Molecular characteristics of occult hepatitis B virus from blood donors in Southeast China

Journal of Clinical Microbiology

Volumn 48, Issue 2, 2010, Pages 357-362

  Yuan, Quan ^a   Ou, Shan Hai ^b   Chen, Chang Rong ^b   Ge, Sheng Xiang ^a   Pei, Bin ^b   Chen, Qing Rui ^a   Yan, Qiang ^a   Lin, Yong Cai ^b   Ni, Hong Ying ^b   Huang, Cheng Hao ^a   Yeo, Anthony E T ^a   Shih, James W K ^a   Zhang, Jun ^a   Xia, Ning Shao ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Blood Service   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD DONOR; CHINA; CHRONIC HEPATITIS; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HYDROPHILICITY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; VIRUS CARRIER;

ADULT; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BLOOD DONORS; CARRIER STATE; CHINA; DNA, VIRAL; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 75649098990     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01781-09     Document Type: Article

References (30)

1. Allain, J. P. 2004. Occult hepatitis B virus infection. Transfus. Clin. Biol. 11:18-25.
2. Blum, H. E., E. Galun, T. J. Liang, F. von Weizsacker, and J. R. Wands. 1991. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J. Virol. 65:1836-1842.
3. Busch, M. P. 2004. Should HBV DNA NAT replace HBsAg and/or anti-HBc screening of blood donors? Transfus. Clin. Biol. 11:26-32.
4. Candotti, D., P. Grabarczyk, P. Ghiazza, R. Roig, N. Casamitjana, P. Iudicone, M. Schmidt, A. Bird, R. Crookes, E. Brojer, M. Miceli, A. Amiri, C. Li, and J. P. Allain. 2008. Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains. J. Hepatol. 49:537-547.
5. Carman, W. F., A. R. Zanetti, P. Karayiannis, J. Waters, G. Manzillo, E. Tanzi, A. J. Zuckerman, and H. C. Thomas. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
6. Chan, H. L., A. Y. Hui, M. L. Wong, A. M. Tse, L. C. Hung, V. W. Wong, and J. J. Sung. 2004. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 53:1494-1498.
7. Chaudhuri, V., R. Tayal, B. Nayak, S. K. Acharya, and S. K. Panda. 2004. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter. Gastroenterology 127:1356-1371.
8. Chevrier, M. C., M. St.-Louis, J. Perreault, B. Caron, C. Castilloux, J. Laroche, and G. Delage. 2007. Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay. Transfusion 47:1794-1802.
9. Fang, Y., Q. L. Shang, J. Y. Liu, D. Li, W. Z. Xu, X. Teng, H. W. Zhao, L. J. Fu, F. M. Zhang, and H. X. Gu. 2009. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China. J. Infect. 58:383-388.
10. Fang, Y., X. Teng, W. Z. Xu, D. Li, H. W. Zhao, L. J. Fu, F. M. Zhang, and H. X. Gu. 2009. Molecular characterization and functional analysis of occult hepatitis B virus infection in Chinese patients infected with genotype C. J. Med. Virol. 81:826-835.
11. Gerlich, W. H., D. Glebe, and C. G. Schuttler. 2007. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J. Viral Hepat. 14(Suppl. 1):16-21.
12. Grob, P., W. Jilg, H. Bornhak, G. Gerken, W. Gerlich, S. Gunther, G. Hess, H. Hudig, A. Kitchen, H. Margolis, G. Michel, C. Trepo, H. Will, A. Zanetti, and I. Mushahwar. 2000. Serological pattern "anti-HBc alone": report on a workshop. J. Med. Virol. 62:450-455.
13. Hass, M., C. Hannoun, T. Kalinina, G. Sommer, C. Manegold, and S. Gunther. 2005. Functional analysis of hepatitis B virus reactivating in hepatitis B surface antigen-negative individuals. Hepatology 42:93-103.
14. Jaoude, G. A., and C. Sureau. 2005. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus. J. Virol. 79:10460-10466.
15. Jeantet, D., I. Chemin, B. Mandrand, A. Tran, F. Zoulim, P. Merle, C. Trepo, and A. Kay. 2004. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J. Med. Virol. 73:508-515.
16. Kao, J. H., P. J. Chen, M. Y. Lai, and D. S. Chen. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118:554-559.
17. Kreutz, C. 2002. Molecular, immunological and clinical properties of mutated hepatitis B viruses. J. Cell. Mol. Med. 6:113-143.
18. Li, L., P. J. Chen, M. H. Chen, K. F. Chak, K. S. Lin, and S. J. Tsai. 2008. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus. Transfusion 48:1198-1206.
19. Lo, Y. M., E. S. Lo, W. Z. Mehal, M. Sampietro, G. Fiorelli, G. Ronchi, C. H. Tse, and K. A. Fleming. 1993. Geographical variation in prevalence of hepatitis B virus DNA in HBsAg negative patients. J. Clin. Pathol. 46:304-308.
20. Mathet, V. L., M. L. Cuestas, V. Ruiz, M. L. Minassian, C. Rivero, J. Trinks, G. Daleoso, L. M. Leon, A. Sala, B. Libellara, D. Corach, and J. R. Oubina. 2006. Detection of hepatitis B virus (HBV) genotype E carried-even in the presence of high titers of anti-HBs antibodies-by an Argentinean patient of African descent who had received vaccination against HBV. J. Clin. Microbiol. 44:3435-3439.
21. Michalak, T. I., C. Pasquinelli, S. Guilhot, and F. V. Chisari. 1994. Hepatitis B virus persistence after recovery from acute viral hepatitis. J. Clin. Invest. 94:907.
22. Minuk, G. Y., D. F. Sun, R. Greenberg, M. Zhang, K. Hawkins, J. Uhanova, A. Gutkin, K. Bernstein, A. Giulivi, and C. Osiowy. 2004. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology 40:1072-1077.
23. Pollicino, T., G. Raffa, L. Costantino, A. Lisa, C. Campello, G. Squadrito, M. Levrero, and G. Raimondo. 2007. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology 45:277-285.
24. Raimondo, G., J. P. Allain, M. R. Brunetto, M. A. Buendia, D. S. Chen, M. Colombo, A. Craxi, F. Donato, C. Ferrari, G. B. Gaeta, W. H. Gerlich, M. Levrero, S. Locarnini, T. Michalak, M. U. Mondelli, J. M. Pawlotsky, T. Pollicino, D. Prati, M. Puoti, D. Samuel, D. Shouval, A. Smedile, G. Squadrito, C. Trepo, E. Villa, H. Will, A. R. Zanetti, and F. Zoulim. 2008. Statements from the Taormina Expert Meeting on Occult Hepatitis B Virus Infection. J. Hepatol. 49:652-657.
25. Rehermann, B., C. Ferrari, C. Pasquinelli, and F. V. Chisari. 1996. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat. Med. 2:1104-1108.
26. Tian, Y., Y. Xu, Z. Zhang, Z. Meng, L. Qin, M. Lu, and D. Yang. 2007. The amino acid residues at positions 120 to 123 are crucial for the antigenicity of hepatitis B surface antigen. J. Clin. Microbiol. 45:2971-2978.
27. Vitale, F., F. Tramuto, A. Orlando, G. Vizzini, V. Meli, G. Cerame, W. Mazzucco, R. Virdone, U. Palazzo, M. R. Villafrate, A. Tagger, and N. Romano. 2008. Can. the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection? J. Med. Virol. 80:577-582.
28. Yamamoto, K., M. Horikita, F. Tsuda, K. Itoh, Y. Akahane, S. Yotsumoto, H. Okamoto, Y. Miyakawa, and M. Mayumi. 1994. Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J. Virol. 68:2671-2676.
29. Yotsuyanagi, H., K. Yasuda, S. Iino, K. Moriya, Y. Shintani, H. Fujie, T. Tsutsumi, S. Kimura, and K. Koike. 1998. Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology 27:1377-1382.
30. Zeng, G., Z. Wang, S. Wen, J. Jiang, L. Wang, J. Cheng, D. Tan, F. Xiao, S. Ma, W. Li, K. Luo, N. V. Naoumov, and J. Hou. 2005. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China. J. Viral Hepat. 12:609-617.